Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$0.70 USD
-0.01 (-2.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.70 0.00 (0.03%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 8.20% |
ABR | 3.00 |
Earnings ESP
|
33.04% |
---|---|
Current Year | -1.30 |
Next Year | -0.32 |
EPS (TTM) | -2.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.45M | 22.40M | 69.01M | 16.00M |
# of Estimates | 2 | 2 | 2 | 1 |
High Estimate | 27.00M | 40.00M | 117.00M | 16.00M |
Low Estimate | 3.90M | 4.80M | 21.02M | 16.00M |
Year ago Sales | 1.23M | 0.96M | 8.57M | 69.01M |
Year over Year Growth Est. | 1,156.10% | 2,233.33% | 704.97% | -76.81% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.33 | -1.30 | -0.32 |
# of Estimates | 3 | 2 | 3 | 2 |
Most Recent Consensus | -0.62 | -0.62 | -2.50 | NA |
High Estimate | -0.17 | -0.03 | -0.40 | -0.05 |
Low Estimate | -0.62 | -0.62 | -2.50 | -0.58 |
Year ago EPS | -0.72 | -0.68 | -2.61 | -1.30 |
Year over Year Growth Est. | 48.61% | 51.47% | 50.19% | 75.77% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.33 | -1.30 | -0.32 |
7 Days Ago | -0.37 | -0.33 | -1.30 | -0.32 |
30 Days Ago | -0.59 | -0.52 | -1.78 | -0.95 |
60 Days Ago | -0.59 | -0.52 | -1.78 | -0.95 |
90 Days Ago | -0.59 | -0.52 | -1.78 | -0.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.03 | -0.70 | -0.32 |
Zacks Consensus Estimate | -0.37 | -0.33 | -1.30 | -0.32 |
Earnings ESP | 33.04% | 90.77% | 46.15% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.66 | -0.68 | -0.72 | NA |
Estimate | -0.61 | -0.63 | -0.65 | -0.40 | NA |
Difference | 0.05 | -0.03 | -0.03 | -0.32 | -0.08 |
Surprise | 8.20% | -4.76% | -4.62% | -80.00% | -20.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more